Fig 2.
Model-derived individual cycloserine (A, top) and clofazimine (B, bottom) exposure metrics: total (protein-bound plus unbound) area under the concentration–time curve from 0 to 24 hours (AUC0-24h) and maximum concentration (Cmax) in plasma and CSF. The dots represent individual values, while the horizontal line indicates the median for each group.
